Welcome to our dedicated page for Origin Agritech SEC filings (Ticker: SEED), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Origin Agritech’s SEC disclosures weave together molecular biology, Chinese GMO regulations, and royalty streams from seed licensing—all inside dense 10-K and 10-Q exhibits. Finding the note on phytase-corn approvals or tracing gene-editing R&D costs can mean reading 200-plus pages.
Stock Titan’s AI untangles that complexity. Our system delivers clear, AI-powered summaries and real-time alerts, so understanding Origin Agritech SEC documents with AI feels as direct as reading a headline. The platform captures every Origin Agritech 8-K material events explained within minutes of EDGAR release and flags Origin Agritech insider trading Form 4 transactions the moment executives buy or sell shares.
- AI-powered summaries of Origin Agritech 8-K material events explained
- Instant alerts on Origin Agritech Form 4 insider transactions real-time
- Concise breakdowns for each Origin Agritech quarterly earnings report 10-Q filing
- Origin Agritech annual report 10-K simplified into key ratios and timelines
- Full text plus context for the Origin Agritech proxy statement executive compensation tables
Use these insights to monitor licensing revenue milestones, compare margins across hybrid-seed lines, or spot an Origin Agritech executive stock transactions Form 4 before a new trait approval. Analysts rely on our Origin Agritech earnings report filing analysis to track R&D spend, while traders watch regulatory footnotes for catalysts. Every filing, every footnote—delivered when it matters.
Origin Agritech Limited filed Amendment No. 2 to a Form F-3 shelf to register up to $30,000,000 of ordinary shares, warrants, and units, to be offered from time to time for three years after effectiveness.
The company may sell these securities directly, through agents or dealers, or via underwriters, with specific terms and any net proceeds disclosed in a future prospectus supplement. Its ordinary shares trade on Nasdaq as SEED; on October 10, 2025, the closing price was $1.44.
Origin is a British Virgin Islands holding company whose operations are in China, including through variable interest entities (the VIE portion is Hainan Aoyu). On September 19, 2025, Origin Biotechnology updated its VIE contractual framework (proxy/POA, share pledge, master exclusive service, business cooperation, and exclusive option agreements), which together provide contractual control and economic benefits and support consolidation under U.S. GAAP.
The filing highlights PRC-related risks, including required CSRC filings within three business days after each issuance and reliance on a Seed Production and Operation License. The auditor is Enrome LLP (Singapore), registered with the PCAOB, and the company states it has not been identified as a Commission‑Identified Issuer under the HFCAA.
FAQ
What is the current stock price of Origin Agritech (SEED)?
What is the market cap of Origin Agritech (SEED)?
